Authors: DURKEN M SCHNEIDER EM BLUTTERSSAWATZKI R STOLLMANNGIBBELS B NESSLER G BRETZ R KORHOLZ D PROBST EN HOLSTENGRIFFIN H HARPS E ZANDER AR JANKA GE

Citation: M. Durken et al., TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, HLH, WITH BONE-MARROW TRANSPLANTATION, Klinische Padiatrie, 210(4), 1998, pp. 180-184

Authors: JANKA GE HARMS D RAUSCHE T LOLIGER C

Citation: Ge. Janka et al., ANTIPLATELET ANTIBODIES (AB) IN THIOPURINE THERAPY OF CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 90(10), 1997, pp. 3830-3830

Authors: DRESOW B FISCHER R JANKA GE GABBE EE

Citation: B. Dresow et al., HPLC-BASED MEASUREMENT OF THE CHELATOR 1,2-DIMETHYL-3-HYDROXY-PYRID-4-ONE (L1) AND ITS IRON COMPLEX FOR PHARMACOKINETIC STUDIES IN HUMANS, Fresenius' journal of analytical chemistry, 352(6), 1995, pp. 562-564

Authors: NIELSEN P FISCHER R ENGELHARDT R TONDURY P GABBE EE JANKA GE

Citation: P. Nielsen et al., LIVER IRON STORES IN PATIENTS WITH SECONDARY HEMOSIDEROSIS UNDER IRONCHELATION-THERAPY WITH DEFEROXAMINE OR DEFERIPRONE, British Journal of Haematology, 91(4), 1995, pp. 827-833